Genepeutic Bio or GNPT is the first GMP-certified cell and gene therapy biotech company in Thailand. It was founded in 2020 to deliver the next wave of personalized cell and gene therapy for patients in Asia. Its missions are to facilitate the advancement of the research and development (R&D) products to commercialization for the treatment of cancers and genetic diseases, to provide more accessible and affordable cell and gene therapy for patients in Southeast Asia and globally; and to support Thailand toward becoming a medical hub in gene and cell therapy that meets international standards.